Cargando…
Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
BACKGROUND AND PURPOSE: Current pieces of evidence support the short-term use of dual antiplatelet (DAPT) in minor ischemic stroke or transient ischemic attack (TIA) based on the studies performed in patients with a broad range of non-cardioembolic stroke mechanisms. However, the efficacy and safety...
Autores principales: | Lin, Chun-Jen, Tseng, Tzu-Yun, Saver, Jeffrey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510375/ https://www.ncbi.nlm.nih.gov/pubmed/36172029 http://dx.doi.org/10.3389/fneur.2022.923142 |
Ejemplares similares
-
Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis
por: Xie, Wuxiang, et al.
Publicado: (2015) -
Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021) -
Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons
por: Hong, Keun-Sik
Publicado: (2014) -
Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
por: Albay, Christessa Emille Que, et al.
Publicado: (2020) -
Appropriate use of antiplatelet medications following transient ischemic attacks and stroke: a 9-year study from the Middle East
por: Naveed, Hiba, et al.
Publicado: (2023)